Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
180 participants
OBSERVATIONAL
2021-08-01
2022-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aromatherapy Methods in Reducing Anxiety Before Breast Biopsy
NCT05276505
Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors
NCT07133087
The Effect of Neoadjuvant Chemotherapy on Physical Functions
NCT06986005
Arm Exercise Capacity and Maximal Oxygen Consumption With Breast Cancer
NCT06018038
Body Awareness and Functionality in Lymphedema
NCT06036173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast cancer
Sixty patients with grade I-II-III breast cancer, whose primary treatment (surgery, radiotherapy and/or chemotherapy) is continuing, who applied to the Hospital Breast Unit clinic, will be included in the study. Patients with problems in reading and writing in Turkish, poor cognitive functions and a serious chronic disease, musculoskeletal pain or disease, severe psychiatric illness, current cancer attack or metastasis will be excluded from the study
None intervention
None intervention
Breast cancer survivors
Sixty patients with grade I-II-III breast cancer, whose primary treatment (surgery, radiotherapy and/or chemotherapy) was completed at least three months ago, who applied to the Hospital Breast Unit clinic, will be included in the study. Patients with problems in reading and writing in Turkish, poor cognitive functions and a serious chronic disease, musculoskeletal pain or disease, severe psychiatric illness, current cancer attack or metastasis will be excluded from the study
None intervention
None intervention
Healthy people
healthy individuals matched for age and gender will also be included in the study.
None intervention
None intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
None intervention
None intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient whose first treatment was completed at least three months ago (surgery, radiotherapy and / or chemotherapy)
* 18-75 years old woman
* Does not have a Turkish literacy problem
Exclusion Criteria
* Having severe musculoskeletal pain or disease
* Serious psychiatric illness
* Patients with current cancer attack or metastasis
* Persons with cognitive impairment
18 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acibadem University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nuray Alaca
Assoc Prof. Nuray Alaca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Acıbadem University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATADEK-2021/14/16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.